PlainRecalls
FDA Drug Moderate Class II Terminated

Metoprolol Succinate Extended-Release Tablets, USP, 25 mg, Rx Only, 100 Tablets per bottle, Manufactured by: Alkem Laboratories Ltd., Mumbai - 400 013, India, Distributed by: Ascend Laboratories, LLC, Parsippany, NJ, 07054, NDC 67877-590-01.

Reported: February 2, 2022 Initiated: January 12, 2022 #D-0393-2022

Product Description

Metoprolol Succinate Extended-Release Tablets, USP, 25 mg, Rx Only, 100 Tablets per bottle, Manufactured by: Alkem Laboratories Ltd., Mumbai - 400 013, India, Distributed by: Ascend Laboratories, LLC, Parsippany, NJ, 07054, NDC 67877-590-01.

Reason for Recall

Failed Dissolution Specifications.

Details

Recalling Firm
Ascend Laboratories, LLC
Units Affected
9216 bottles
Distribution
Nationwide in the USA
Location
Parsippany, NJ

Frequently Asked Questions

What product was recalled?
Metoprolol Succinate Extended-Release Tablets, USP, 25 mg, Rx Only, 100 Tablets per bottle, Manufactured by: Alkem Laboratories Ltd., Mumbai - 400 013, India, Distributed by: Ascend Laboratories, LLC, Parsippany, NJ, 07054, NDC 67877-590-01.. Recalled by Ascend Laboratories, LLC. Units affected: 9216 bottles.
Why was this product recalled?
Failed Dissolution Specifications.
Which agency issued this recall?
This recall was issued by the FDA Drug on February 2, 2022. Severity: Moderate. Recall number: D-0393-2022.